ArticleSignal transduction and targeted therapy2022

Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo.

Hanjun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.